Michael R. Nadorff

Dr. Michael R. Nadorff


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2021 in Sleep Medicine
Verified
Journal Article
Closed access
Charles MorinCharles Morin
Charles Morin
BBBjørn Bjorvatn
Bjørn Bjorvatn
FCFrances Chung
Frances Chung
BHBrigitte Holzinger
Brigitte Holzinger
MPMarkku Partinen
Markku Partinen
CEColin A. Espie
Colin A. Espie

28 December 2012 in Suicide and Life-Threatening Behavior
Verified
Journal Article
Closed access
PDF file
MNMichael R. Nadorff
Michael R. Nadorff
SNSarra Nazem
Sarra Nazem
AFAmy Fiske
Amy Fiske

1 January 2014 in Journal of Affective Disorders
Verified
Journal Article
Closed access
MNMichael R. Nadorff
Michael R. Nadorff
MAMichael D. Anestis
Michael D. Anestis
SNSarra Nazem
Sarra Nazem
HHH. Claire Harris
H. Claire Harris
EWE. Samuel Winer
E. Samuel Winer

15 July 2015 in Journal of Clinical Sleep Medicine
Verified
Journal Article
Closed access
MNMichael R. Nadorff
Michael R. Nadorff
Danielle NadorffDanielle Nadorff
Danielle Nadorff
AGAnne Germain
Anne Germain
Nightmares are a robust and modifiable predictor of increased suicidality and poor psychiatric outcomes, yet nightmare screening and treatment remain rare, even in sleep centers. This paper aims to examine what proportion of nightmare sufferers have discussed nightmares with a healthcare provider, as well as possible explanations for low rates of nightmare complaints. The present study utilized a large United States community sample recruited through mTurk and a student sample recruited from a large public university in the Southeast United States. In Study 1, participants (n = 809) were asked whether they had discussed nightmares with a healthcare provider. In Study 2 participants (n = 747) were asked whether they believed nightmares were treatable in addition to whether or not they had discussed nightmares with a healthcare provider. Of the participants in Study 1 experiencing clinically significant nightmare symptoms only 37.8% of participants reported discussing their nightmares with a healthcare professional. In Study 2 only 11.1% of participants with significant nightmares reporting having told a healthcare provider about their nightmares. Further, of these individuals with clinically significant nightmare symptoms, less than one-third believed that nightmares were treatable. Higher nightmare severity was associated with a greater likelihood of reporting nightmares to a healthcare physician as well as with lower beliefs that nightmares are treatable. Our findings suggest that nightmares are rarely reported to healthcare providers, which may explain the underutilization of nightmare treatments. Given the poor outcomes associated with nightmares, nightmare screening is warranted.

1 March 2018 in Sleep Medicine Clinics
Verified
Journal Article
Closed access
MNMichael R. Nadorff
Michael R. Nadorff
CDChristopher W. Drapeau
Christopher W. Drapeau
WPWilfred R. Pigeon
Wilfred R. Pigeon

7 February 2013 in Behavioral Sleep Medicine
Verified
Journal Article
Closed access
MNMichael R. Nadorff
Michael R. Nadorff
BPBen Porter
Ben Porter
HRHoward M. Rhoades
Howard M. Rhoades
AGAnthony J. Greisinger
Anthony J. Greisinger
MKMark E. Kunik
Mark E. Kunik
MSMelinda A. Stanley
Melinda A. Stanley
This study investigated the relation between generalized anxiety disorder (GAD) and frequency of bad dreams in older adults. A secondary analysis from a randomized clinical trial comparing cognitive behavioral therapy (CBT) for anxiety to enhanced usual care (EUC) assessed bad dream frequency at baseline, post treatment (3 months), and at 6, 9, 12, and 15 months. Of 227 participants (mean age = 67.4), 134 met GAD diagnostic criteria (CBT = 70, EUC = 64), with the remaining 93 serving as a comparison group. Patients with GAD had significantly more bad dreams than those without, and bad dream frequency was significantly associated with depression, anxiety, worry, and poor quality of life. CBT for anxiety significantly reduced bad dream frequency at post treatment and throughout follow up compared to EUC.